Examining the link between diabetic neuropathy and muscle mass in type 2 diabetes patients
Official title: The Relation Between Diabetic Neuropathy and Muscle Mass in Type 2 Diabetes Mellitus Patients
Run by Ain Shams University · NCT06958302 · Data updated 2026-11-12
This study looks at how diabetic nerve damage affects muscle mass and strength in people over 45 with type 2 diabetes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 45 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Ain Shams University Academic / other |
| Locations | 2 sites (Cairo, Abbassia and 1 other locations) |
| Status | Recruiting |
| Started | May 30, 2025 |
| Main results expected | November 10, 2025 |
| Study ends | June 15, 2026 |
| Registry record updated | May 6, 2025 |
| Trial ID | NCT06958302 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients diagnosed with type 2 diabetes mellitus who are aged 45 years or older.
✕Probably not a fit
Patients with type 1 diabetes, gestational diabetes, or those with severe comorbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the relationship between diabetic neuropathy and muscle mass in patients with type 2 diabetes mellitus aged over 45. It utilizes ultrasound to measure anterior thigh muscle thickness, adjusting for body mass index to calculate muscle mass. Participants will undergo clinical tests, including hand grip strength and chair stand tests, to assess muscle power and function. The study will also investigate the prevalence of sarcopenia in this population and its correlation with diabetic neuropathy, as determined by nerve conduction studies.
Why it matters
Potential benefit: If successful, this study could enhance understanding of the interplay between muscle mass and diabetic neuropathy, potentially leading to improved management strategies for patients with type 2 diabetes.
How similar studies have gone: While there have been studies examining aspects of diabetic neuropathy and muscle mass, this specific observational approach focusing on the relationship in type 2 diabetes patients is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * The study group consisted of patients diagnosed with Type 2 diabetes mellitus aged ≥45 years old Exclusion Criteria: * Type 1 DM, gestational diabetes mellitus * Severe cardiopulmonary disease, significant/previous neurological disorder (e.g., ischemic stroke, Parkinson disease) causing difficulty during daily activities (e.g., walking), visual deficit, and psychiatric problem * Other neuropathy-associated factors such as: alcohol, nutrition, poisoning and drug addiction * Patients with renal diseases, malignancy and autoimmune diseases * Patients on long term use of Steroids
Where it's running
-
Ain Shams university
Cairo, Abbassia, Egypt Recruiting -
Ain Shams university
Cairo, Abbassia, Egypt Recruiting
Study contacts
- Study coordinator: Wafaa M Mohamed Abd ElAzim, Masters degree
- Email: wafaa.mahmoud@med.asu.edu.eg
- Phone: +201012932752
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sarcopenia in Patients After Cardiac Surgery
This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.
-
Bone marrow mesenchymal stem cell injection for sarcopenia
This study tests whether CG-BM1, a stem cell injection, can be safely given to adults with sarcopenia to see if it helps improve muscle health.
-
GLP-1 receptor agonist use and muscle health in adults with obesity without diabetes
This study tests whether GLP-1 receptor agonists affect muscle mass and strength in adults with obesity who don’t have diabetes.
-
Sarcopenia and Epidural Steroid Injections in Lumbar Spinal Stenosis
We’re testing how sarcopenia relates to pain, function, and quality of life after a routine interlaminar epidural steroid injection in people with lumbar spinal stenosis.
-
Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients
This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.
-
Lower-limb rehabilitation robot training with nutrition education for sarcopenia
In adults aged 60 and older with sarcopenia, this study tests whether adding robot-assisted leg training to nutrition education can improve muscle mass and walking ability compared with usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.